Read More Pharma Industry News FDA engagement signals cautious progress for AEON Biopharma Inc. in complex biologics space (NYSE American: AEON) AEON Biopharma advances ABP-450 biosimilar strategy. Discover what this means for BOTOX competition, pricing, and biotech market dynamics. bySoujanya RaviMarch 28, 2026